ITC SHARES GAIN; FMCG MAJOR STARTS CLINICAL TRIALS OF NASAL SPRAY FOR COVID-19 PREVENTION

© Provided by CNBCTV18 ITC share price gained over 1.5 percent on Thursday after the FMCG major said that it has initiated clinical trials for developing a nasal spray for COVID-19 prevention. The company plans to market the nasal spray under the ‘Savlon’ brand. if (typeof colombia == 'undefined') { var colombia = colombia || {}; colombia...

Source: